1 / 6

European Injectable Drug Delivery Market worth $207.3 Billion by 2020

European Injectable Drug Delivery Market report categorizes the europe market by Therapeutic (Oncology, Hormonal), Type (Formulation, Device), Administration (Musculoskeletal, Skin), Usage Pattern (Immunization, Curative Care), End User (Hospital, Home care Setting) & Geography.

Manoj7645
Télécharger la présentation

European Injectable Drug Delivery Market worth $207.3 Billion by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MarketsandMarkets Presents European Injectable Drug Delivery Market - Global Forecasts to 2020 https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

  2. The European Injectable Drug Delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Injectable drug delivery offers a promising alternative for the delivery of drugs that are ineffective when administered orally. Injectable drug delivery is aimed to maximize patient compliance and reduce the frequency of dosage administration without compromising the effectiveness of the treatment. • The report segments the European injectable drug delivery market on the basis of types, therapeutic applications, usage patterns, modes of administration, end users, and regions. On the basis of type, the formulations segment is expected to account for the largest share in 2015, closely followed by the devices segment. The formulations segment is expected to grow at the highest CAGR during the forecast period, owing to the rising prevalence of chronic diseases, increase in demand of self-injection devices, growth of the biologics market, technological advancements, emphasis on innovation of formulations, and benefits such high efficacy and reduced side effects offered by formulations. The formulations market is further segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The devices market is further segmented into conventional injection devices, self-injections, and other devices. https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

  3. https://www.marketsandmarkets.com/Market-Reports/european-injectable-https://www.marketsandmarkets.com/Market-Reports/european-injectable- drug-delivery-market-1205.html Geographically, the market is dominated by Germany, followed by France. Germany is expected to account for the largest share of the European injectable drug delivery market in 2015, with the highest growth rate during the forecast period. https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

  4. • On the basis of therapeutic application, the European injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other therapeutic applications. On the basis of usage pattern, the market is segmented into curative care, immunization, and others. • On the basis of mode of administration, the European injectable drug delivery market is segmented into skin, organs, central nervous system, and circulatory/musculoskeletal system. On the basis of end user, the market is segmented into hospitals/clinics, home care settings, research laboratories, pharma and biotech companies, and other end users. https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

  5. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.linkedin.com/company/marketsandmarkets http://twitter.com/marketsmarkets https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

  6. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, electronics, and telecommunications and IT. banking and financial services, pharmaceuticals, semiconductor and We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/european-injectable-drug-delivery-market-1205.html

More Related